XML 29 R32.htm IDEA: XBRL DOCUMENT  v2.3.0.11
STOCK-BASED COMPENSATION (Details 2) (USD $)
Share data in Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Jul. 31, 2011
Jul. 25, 2010
Jul. 31, 2011
Jul. 25, 2010
Stock-based compensation expense, along with the related income tax benefit        
Stock based compensation expense recognized $ 2,578,000 $ 2,682,000 $ 14,820,000 $ 11,868,000
Income tax benefit recognized (979,000) (1,028,000) (5,629,000) (4,548,000)
Stock based compensation expense, net of tax 1,599,000 1,654,000 9,191,000 7,320,000
Stock-based compensation expense unrecognized 14,500,000   14,500,000  
Period for recognition of unrecognized stock-based compensation expense (in years) 2.7   2.7  
Stock options
       
Stock-based compensation        
Cash received from stock options exercised 6,800,000 2,600,000 50,500,000 16,800,000
Tax benefit realized from stock options, aggregate 4,200,000 1,200,000 19,100,000 8,600,000
Reconciliation of Stock Options        
Outstanding, at the beginning of the period (in shares)     22,048  
Granted (in shares)     2,648  
Exercised (in shares)     (4,437)  
Forfeited (in shares)     (20)  
Outstanding, at the end of the period (in shares) 20,239   20,239  
Exercisable at the end of the period (in shares) 13,967   13,967  
Weighted-Average Exercise Price        
Outstanding at the beginning of the period (in dollars per share)     $ 16.47  
Granted (in dollars per share) $ 24.95   $ 24.95  
Exercised (in dollars per share) $ 15.34   $ 15.34  
Forfeitures (in dollars per share) $ 18.71   $ 18.71  
Outstanding at the end of the period (in dollars per share) $ 17.83   $ 17.83  
Exercisable at end of period (in dollars per share) $ 16.54   $ 16.54  
Weighted Average Remaining Contractual Term        
Outstanding at the end of the period (in years) 5.9   5.9  
Exercisable at end of period (in years)     4.7  
Aggregate Intrinsic Value (in thousands)        
Outstanding at the end of the period 225,536,000   225,536,000  
Exercisable at end of period 173,653,000   173,653,000  
Weighted-average grant date fair value of stock options granted, and the total intrinsic value of options exercised        
Weighted average Grant Date Fair Value (in dollars per share)     $ 5.54 $ 4.55
Intrinsic value of exercised options 11,124,000 3,334,000 50,312,000 22,559,000
Weighted-average assumptions used to calculate fair value of each ordinary option award        
Risk free interest rate (as a percent)     3.00% 3.40%
Expected Dividend Rate (as a percent)     2.00% 2.20%
Expected stock price volatility rate (as a percent)     21.00% 22.00%
Expected option Term (in years)     8 8
Nonvested shares
       
Reconciliation of the nonvested shares        
Nonvested shares at the beginning of the period (in shares)     206  
Nonvested shares granted in period (in shares)     45  
Nonvested shares vested in period (in shares)     (20)  
Nonvested shares at the end of the period (in shares) 231   231  
Weighted-Average Grant-Date Fair Value        
Nonvested shares at the beginning of the period (in dollars per share)     $ 18.13  
Nonvested shares granted in period (in dollars per share)     $ 24.84 $ 19.56
Nonvested shares vested in period (in dollars per share)     $ 16.77  
Nonvested shares at the end of the period (in dollars per share) $ 19.55   $ 19.55  
Weighted-average grant date fair value of nonvested shares granted, and fair value of nonvested shares granted and vested        
Weighted average grant date fair value of nonvested shares granted (in dollars per share)     $ 24.84 $ 19.56
Fair value of nonvested shares granted     1,118,000 978,000
Fair value of nonvested shares vested     $ 335,000 $ 664,000